Target intelligence / Profile preview

Human Leukocyte Antigen Class I Molecule

Molecular classification
Receptor, MHC Class I, Glycoprotein
01

Overview

Human leukocyte antigen (HLA) class I molecules are cell surface glycoproteins encoded by genes within the major histocompatibility complex (MHC) on chromosome 6. They play a central role in the adaptive immune system by presenting peptide antigens derived from intracellular proteins to CD8+ cytotoxic T lymphocytes, enabling recognition and elimination of infected or malignant cells. HLA class I molecules are heterodimers composed of a polymorphic heavy (α) chain and a non-polymorphic light chain called β2-microglobulin. The α chain consists of three extracellular domains (α1, α2, and α3), a transmembrane region, and a short cytoplasmic tail. The α1 and α2 domains form the peptide-binding groove. Classical HLA class I molecules (HLA-A, -B, -C) are highly polymorphic, enabling presentation of a wide array of antigenic peptides. Nonclassical class I molecules (e.g., HLA-E, HLA-F, HLA-G) exhibit limited polymorphism and have specialized functions. HLA class I molecules are expressed on nearly all nucleated cells and present endogenous peptides to CD8+ T lymphocytes for immune surveillance and response initiation.

02

Biological functions

Antigen presentationImmune responseT cell activationImmune surveillance
03

Disease associations

CancerInfectionAutoimmune diseasesTransplant rejection
04

Safety considerations

Altered expression or function can contribute to immune evasion by tumorsRole in autoimmune diseases presents a therapeutic challenge
05

Biomarkers

HLA allele typing (for transplant compatibility, disease susceptibility)Expression levels in cancer (potential predictive biomarker for immunotherapy response)

Beyond the preview

Go deeper on Human Leukocyte Antigen Class I Molecule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human Leukocyte Antigen Class I Molecule.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call